当前位置:首页 - 行情中心 - 百诚医药(301096) - 财务分析 - 现金流量表

百诚医药

(301096)

  

流通市值:48.96亿  总市值:64.60亿
流通股本:8278.72万   总股本:1.09亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金197,166,542.198,676,390.84575,158,616.73419,003,596.04
  收到的税费返还--33,229,411.9222,158,189.89
  收到其他与经营活动有关的现金14,363,165.1110,048,757.2543,651,765.2834,852,576.79
  经营活动现金流入小计211,529,707.21108,725,148.09652,039,793.93476,014,362.72
  购买商品、接受劳务支付的现金107,851,623.4755,829,619.42316,569,736.04236,707,982.22
  支付给职工以及为职工支付的现金150,080,765.7184,350,187.6342,685,045.7265,989,264.23
  支付的各项税费9,644,269.859,237,777.6627,972,057.9725,169,332.42
  支付其他与经营活动有关的现金58,372,287.2329,337,444.61160,669,879.86131,203,344.77
  经营活动现金流出小计325,948,946.26178,755,029.29847,896,719.57659,069,923.64
  经营活动产生的现金流量净额-114,419,239.05-70,029,881.2-195,856,925.64-183,055,560.92
二、投资活动产生的现金流量:
  收回投资收到的现金---1,364,263.67
  处置固定资产、无形资产和其他长期资产收回的现金净额16,287.1516,287.15-2,984,800.94
  收到的其他与投资活动有关的现金238,624,269.71128,015,986.27472,533,753.97201,248,965.04
  投资活动现金流入小计238,640,556.86128,032,273.42472,533,753.97205,598,029.65
  购建固定资产、无形资产和其他长期资产支付的现金58,497,334.0940,593,856.89395,104,433.86392,873,637.39
  投资支付的现金6,650,0005,000,00061,116,00023,116,000
  取得子公司及其他营业单位支付的现金--13,426,477.1713,426,477.17
  支付其他与投资活动有关的现金309,666,134.38171,224,321.73467,424,302.69339,610,319.29
  投资活动现金流出小计374,813,468.47216,818,178.62937,071,213.72769,026,433.85
  投资活动产生的现金流量净额-136,172,911.61-88,785,905.2-464,537,459.75-563,428,404.2
三、筹资活动产生的现金流量:
  吸收投资收到的现金--9,383,342.989,383,342.98
  其中:子公司吸收少数股东投资收到的现金--490,000-
  取得借款收到的现金510,000,000200,000,0001,244,337,320664,400,000
  筹资活动现金流入小计510,000,000200,000,0001,253,720,662.98673,783,342.98
  偿还债务支付的现金266,400,00080,000,000905,500,000435,000,000
  分配股利、利润或偿付利息支付的现金9,462,858.544,240,761.0948,771,181.1544,421,631.98
  支付其他与筹资活动有关的现金231,335.24105,086.821,359,430.34990,256.08
  筹资活动现金流出小计276,094,193.7884,345,847.91955,630,611.49480,411,888.06
  筹资活动产生的现金流量净额233,905,806.22115,654,152.09298,090,051.49193,371,454.92
四、汇率变动对现金及现金等价物的影响326,514.9-30,408.9112,965.021,720.59
五、现金及现金等价物净增加额-16,359,829.54-43,192,043.22-362,291,368.88-553,110,789.61
  加:期初现金及现金等价物余额416,161,346.06416,161,346.06778,452,714.94778,452,714.94
  期末现金及现金等价物余额399,801,516.52372,969,302.84416,161,346.06225,341,925.33
补充资料:
  净利润3,098,160.54--52,922,991.09-
  资产减值准备6,728,581.21-41,000,148.95-
  固定资产和投资性房地产折旧77,147,845.07-141,830,582.73-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧77,147,845.07-141,830,582.73-
  无形资产摊销1,833,568.4-3,480,557.58-
  长期待摊费用摊销294,791.88-357,178.23-
  固定资产报废损失--9,875.23-
  财务费用9,673,278.07-17,040,096.57-
  投资损失-1,688,430.57-5,591,708.21-
  递延所得税802,123.12-12,876,726.84-
  其中:递延所得税资产减少802,123.12-12,876,726.84-
  存货的减少-28,470,143.12--88,198,739.9-
  经营性应收项目的减少-161,045,313.25--252,405,023.4-
  经营性应付项目的增加-23,135,554.11-3,261,281.03-
  其他---28,268,035.19-
  现金的期末余额399,801,516.52-416,161,346.06-
  减:现金的期初余额416,161,346.06-778,452,714.94-
  现金及现金等价物的净增加额-16,359,829.54--362,291,368.88-
公告日期2025-08-272025-04-232025-04-232024-10-29
审计意见(境内)标准无保留意见
TOP↑